News Focus
News Focus
icon url

Hoskuld

09/16/25 1:02 PM

#500747 RE: sab63090 #500740

I took it on faith that Missling knew how to run trials for his own product. And he didn't. But having failed the trials, approval was not even a possibility.

AD is completely different. The trial was wildly successful. The only weakness now is no confirmatory trial. Will that matter? I hope not.